Jessica Sims Receives Scholar-in-Training Award
Jessica Sims, PhD, a postdoctoral scientist at Cedars-Sinai, has received a Scholar-in-Training Award from the American Association for Cancer Research (AACR). The competitive award provides young scientists with financial support to attend educational conferences and meetings.
In her winning abstract, Sims describes her findings from a study demonstrating that a HER3-binding nanoparticle, called HerDox, targets Herceptin-resistant breast cancer cells and induces significant cell death. Sims and colleagues also showed that HerDox has the potential to be effective as part of a combination therapy. The in vitro experiments were conducted by Sims under the direction of principal investigator Lali Medina-Kauwe, PhD, associate professor in the Cedars-Sinai Department of Biomedical Sciences.
Sims joined the Medina-Kauwe lab in 2011 after completing her doctoral studies in cellular and molecular physiology at Tufts University in Massachusetts. At Tufts, she focused on breast cancer metastasis and the identification of new therapies to prevent and reduce tumor migration and invasion. At Cedars-Sinai, she continues to study breast cancer while gaining additional training.
"The Medina-Kauwe laboratory has enabled me to pursue these interests as well as expand my knowledge about nanotechnology and nanomedicine," Sims said. She said her goal is to devise novel therapies for drug-resistant and metastatic breast cancers.
With the support of the Scholar-in-Training award, Sims will attend the annual CTRC-AACR San Antonio Breast Cancer Symposium in November. The symposium, presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine in Houston, brings together basic scientists and clinicians to advance progress in breast cancer research.
Sims recently received another honor when she was invited to attend the Translational Cancer Research for Basic Scientists Workshop in November in Boston. Presented by the AACR, the intensive, weeklong meeting will give participants insight into the latest methods and approaches in translational cancer research.
Photo: Jessica Sims, PhD, says her goal as a scientist is to devise novel therapies for drug-resistant and metastatic breast cancers.